(APN) Aplisens - Ratings and Ratios
Pressure,Sensors,Transmitters,Controllers,Regulators
APN EPS (Earnings per Share)
APN Revenue
Description: APN Aplisens
Aplisens S.A. is a Polish company specializing in the manufacture and sale of process instrumentation, primarily focused on electronic pressure and differential pressure measurement technology. The companys diverse product portfolio includes pressure transmitters, level probes, temperature sensors, and flow meters, among others, catering to various industries. Aplisens also provides a range of accessories and solutions, including diaphragm seals, valve manifolds, and power supplies.
From a financial perspective, Aplisens has a market capitalization of 208.78M PLN, indicating a relatively modest size. The companys price-to-earnings ratio stands at 11.36, suggesting a potentially undervalued stock. The return on equity (RoE) is 7.98%, which, while not exceptional, demonstrates a reasonable level of profitability. To further assess the companys financial health, it would be useful to examine additional KPIs such as revenue growth, debt-to-equity ratio, and operating margin.
Analyzing Aplisens product offerings and industry focus, it is evident that the company operates in a niche segment within the broader electronic equipment and instruments sector. The demand for process instrumentation is often driven by industries such as oil and gas, chemicals, and manufacturing, which can be subject to fluctuations in economic cycles. To mitigate this risk, Aplisens has diversified its product portfolio and expanded its customer base across various sectors, including the automotive industry.
To gain a more comprehensive understanding of Aplisens investment potential, it would be essential to examine additional metrics, such as the companys dividend yield, earnings per share (EPS) growth, and industry comparisons. Furthermore, analyzing the companys management team, corporate governance, and research and development initiatives could provide valuable insights into its long-term prospects.
APN Stock Overview
| Market Cap in USD | 56m |
| Sub-Industry | Electronic Equipment & Instruments |
| IPO / Inception |
APN Stock Ratings
| Growth Rating | 36.9% |
| Fundamental | 54.6% |
| Dividend Rating | 71.1% |
| Return 12m vs S&P 500 | -23.4% |
| Analyst Rating | - |
APN Dividends
| Dividend Yield 12m | 3.72% |
| Yield on Cost 5y | 7.69% |
| Annual Growth 5y | 31.95% |
| Payout Consistency | 96.1% |
| Payout Ratio | 61.1% |
APN Growth Ratios
| Growth Correlation 3m | 57.6% |
| Growth Correlation 12m | -23.2% |
| Growth Correlation 5y | 86% |
| CAGR 5y | 15.68% |
| CAGR/Max DD 5y | 0.54 |
| Sharpe Ratio 12m | -0.15 |
| Alpha | -11.05 |
| Beta | -0.299 |
| Volatility | 28.31% |
| Current Volume | 0.1k |
| Average Volume 20d | 0.1k |
| Stop Loss | 18.1 (-3.5%) |
| Signal | -0.49 |
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (17.4m TTM) > 0 and > 6% of Revenue (6% = 8.88m TTM) |
| FCFTA 0.02 (>2.0%) and ΔFCFTA -6.71pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 77.71% (prev 67.87%; Δ 9.83pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 18.9m > Net Income 17.4m (YES >=105%, WARN >=100%) |
| Net Debt (1.64m) to EBITDA (17.3m) ratio: 0.10 <= 3.0 (WARN <= 3.5) |
| Current Ratio 11.96 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (11.1m) change vs 12m ago 0.0% (target <= -2.0% for YES) |
| Gross Margin 36.17% (prev 40.74%; Δ -4.57pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 60.51% (prev 67.23%; Δ -6.73pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -144.0 (EBITDA TTM 17.3m / Interest Expense TTM -120.0k) >= 6 (WARN >= 3) |
Altman Z'' 23.95
| (A) 0.47 = (Total Current Assets 125.5m - Total Current Liabilities 10.5m) / Total Assets 243.7m |
| (B) 0.82 = Retained Earnings (Balance) 199.0m / Total Assets 243.7m |
| warn (B) unusual magnitude: 0.82 — check mapping/units |
| (C) 0.07 = EBIT TTM 17.3m / Avg Total Assets 244.7m |
| (D) 16.87 = Book Value of Equity 199.0m / Total Liabilities 11.8m |
| Total Rating: 23.95 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 54.60
| 1. Piotroski 3.50pt = -1.50 |
| 2. FCF Yield 2.66% = 1.33 |
| 3. FCF Margin 3.74% = 0.93 |
| 4. Debt/Equity 0.05 = 2.50 |
| 5. Debt/Ebitda 0.68 = 2.15 |
| 6. ROIC - WACC 1.80% = 2.25 |
| 7. RoE 7.98% = 0.67 |
| 8. Rev. Trend -30.60% = -1.53 |
| 9. Rev. CAGR -0.48% = -0.08 |
| 10. EPS Trend -19.87% = -0.50 |
| 11. EPS CAGR -13.03% = -1.63 |
What is the price of APN shares?
Over the past week, the price has changed by +0.00%, over one month by -2.34%, over three months by +5.26% and over the past year by -9.85%.
Is Aplisens a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of APN is around 20.06 PLN . This means that APN is currently overvalued and has a potential downside of 6.99%.
Is APN a buy, sell or hold?
What are the forecasts/targets for the APN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 21.6 | 15.2% |
APN Fundamental Data Overview
Market Cap PLN = 206.0m (206.0m PLN * 1.0 PLN.PLN)
CCE Cash And Equivalents = 10.1m PLN (Cash only, last quarter)
P/E Trailing = 11.2121
P/S = 1.3914
P/B = 0.9219
Beta = 0.19
Revenue TTM = 148.1m PLN
EBIT TTM = 17.3m PLN
EBITDA TTM = 17.3m PLN
Long Term Debt = 1.30m PLN (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 10.5m PLN (from totalCurrentLiabilities, last quarter)
Debt = 11.8m PLN (Calculated: Short Term 10.5m + Long Term 1.30m)
Net Debt = 1.64m PLN (calculated as Total Debt 11.8m - CCE 10.1m)
Enterprise Value = 207.6m PLN (206.0m + Debt 11.8m - CCE 10.1m)
Interest Coverage Ratio = -144.0 (Ebit TTM 17.3m / Interest Expense TTM -120.0k)
FCF Yield = 2.66% (FCF TTM 5.53m / Enterprise Value 207.6m)
FCF Margin = 3.74% (FCF TTM 5.53m / Revenue TTM 148.1m)
Net Margin = 11.75% (Net Income TTM 17.4m / Revenue TTM 148.1m)
Gross Margin = 36.17% ((Revenue TTM 148.1m - Cost of Revenue TTM 94.5m) / Revenue TTM)
Tobins Q-Ratio = 1.04 (Enterprise Value 207.6m / Book Value Of Equity 199.0m)
Interest Expense / Debt = 0.31% (Interest Expense 37.0k / Debt 11.8m)
Taxrate = 18.47% (from yearly Tax Provision: 4.91m / 26.6m)
NOPAT = 14.1m (EBIT 17.3m * (1 - 18.47%))
Current Ratio = 11.96 (Total Current Assets 125.5m / Total Current Liabilities 10.5m)
Debt / Equity = 0.05 (Debt 11.8m / last Quarter total Stockholder Equity 226.5m)
Debt / EBITDA = 0.68 (Net Debt 1.64m / EBITDA 17.3m)
Debt / FCF = 2.13 (Debt 11.8m / FCF TTM 5.53m)
Total Stockholder Equity = 218.1m (last 4 quarters mean)
RoA = 7.14% (Net Income 17.4m, Total Assets 243.7m )
RoE = 7.98% (Net Income TTM 17.4m / Total Stockholder Equity 218.1m)
RoCE = 7.88% (Ebit 17.3m / (Equity 218.1m + L.T.Debt 1.30m))
RoIC = 6.46% (NOPAT 14.1m / Invested Capital 218.1m)
WACC = 4.66% (E(206.0m)/V(217.8m) * Re(4.91%)) + (D(11.8m)/V(217.8m) * Rd(0.31%) * (1-Tc(0.18)))
Shares Correlation 5-Years: -100.0 | Cagr: -4.46%
Discount Rate = 4.91% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 76.12% ; FCFE base≈12.1m ; Y1≈10.6m ; Y5≈8.56m
Fair Price DCF = 13.98 (DCF Value 155.7m / Shares Outstanding 11.1m; 5y FCF grow -15.60% → 3.0% )
Revenue Correlation: -30.60 | Revenue CAGR: -0.48%
Rev Growth-of-Growth: -13.93
EPS Correlation: -19.87 | EPS CAGR: -13.03%
EPS Growth-of-Growth: -67.77